News items Jurgen Futterer appointed Professor of Image Guided Oncological Interventions
26 February 2020

Jurgen Fütterer has been appointed Professor of Image-Guided Oncological Interventions at Radboud University/Radboud university medical center with effect from 1 December 2019.
Fütterer is an interventional radiologist and is also Professor at the Robotics and Mechatronics Group at the University of Twente.


The new professor is an expert in the field of cancer imaging techniques, image-guided interventions and robotics. He performs oncological treatments with special attention to MRI-guided interventions (MRI-guided cryoablation (clinical), focal laser ablation (clinical) and targeted therapeutic ultrasound (pre-clinical and clinical).
Jurgen Fütterer (Oosterhout 1975) studied Medicine at Radboud University from 1994 until 2001 and obtained his PhD in 2006 at this university on research into MRI techniques for the localisation and staging of prostate cancer.
He studied radiology at Radboud university medical center, was a guest researcher at Langone New York University and has been working at Radboud university medical center since 2010. Fütterer has published extensively on MRI in prostate cancer and introduced a robotic device for MRI-guided prostate biopsy.
At the Radboud university medical center Prof. Fütterer will focus primarily on translation and implementation of innovative image-guided interventions.

Jurgen Fütterer is a member of the theme Urological cancers.
 

More information


Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items


More than five million euros for research to improve palliative care Jeroen Hasselaar will lead research project with Horizon grant

15 June 2022

Jeroen Hasselaar will lead a large international research project. With a 5.3 million euro grant from the EU's Horizon program, he and his team want to improve palliative care for cancer patients, together with partners from nine European countries.

read more

New test for Lyme disease is not reliable

15 June 2022

To determine whether someone has Lyme disease, doctors in the Netherlands often use antibody tests. For some time now, so-called cellular tests have been available on the market. However, the VICTORY study published in The Lancet Infectious Diseases has found that these tests are not reliable.

read more

Science at Lowlands Music Festival with two Radboudumc research projects

10 June 2022

For the first time since 2019, music festival Lowlands will take place again, on August 19, 20 and 21 in Biddinghuizen. Radboudumc is active at the festival with two studies: "How resilient are you?" and "Dr. Borrel or Dr. Bob?"

read more

Body composition is more important than BMI for renal cancer survival rates

11 January 2022

Body composition is important for survival rates in renal cell cancer. Research from the Radboudumc shows that low muscle quality and low organ fat are associated with poor survival. This involves different stages of renal cancer, ranging from stage I-III to stage IV.

read more

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

read more

Research into treatment for bladder pain syndrome will now be reimbursed

4 August 2021

Bladder pain syndrome, also called interstitial cystitis, is a chronic benign condition of the urinary bladder

read more